Individualization of phenytoin dosage regimens

Area of Science:

• Pharmacokinetics
• Clinical Pharmacology
• Drug Dosing

Background:

• Optimizing phenytoin dosage is crucial for therapeutic efficacy and minimizing toxicity.
• Individual patient variability necessitates personalized dosing strategies for anticonvulsant medications.

Purpose of the Study:

• To compare the efficacy of two methods for determining optimal individual phenytoin dosage regimens.
• To evaluate the accuracy of individual pharmacokinetic parameters versus a nomogram in predicting phenytoin serum concentrations.

Main Methods:

• Two methods were assessed in 12 patients: (1) estimation of individual Michaelis-Menten pharmacokinetic parameters using two steady-state phenytoin concentrations, and (2) application of a published nomogram.
• Dosage regimens were calculated based on individual parameters and nomogram recommendations.
• Observed steady-state phenytoin serum levels were compared with predicted levels.

Main Results:

• Regimens calculated using individual pharmacokinetic parameters showed good agreement with observed levels (r=0.824, p<0.02), with a small average deviation of 0.04 μg/ml.
• The nomogram method yielded a weaker but significant correlation (r=0.360, p<0.05) with a larger average deviation of -3 μg/ml.
• One patient's nomogram-indicated dose exceeded their estimated maximal metabolic rate.

Conclusions:

• Estimating individual pharmacokinetic parameters is a practical and superior method for optimizing phenytoin dosage regimens compared to the nomogram.
• Personalized pharmacokinetic profiling enhances the precision of phenytoin dosing, leading to better patient outcomes.